© Reuters. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo
WASHINGTON (Reuters) – Illumina Inc (NASDAQ:) filed an appeal late on Monday against an order by the U.S. Federal Trade Commission, which is demanding that the company divest cancer diagnostic test maker Grail Inc because of concern that its ownership would stifle competition in the U.S. market for cancer tests.
Heritage World Inc. (NASDAQ:HGBL) Q1 2025 Earnings Convention Name Might 8, 2025 5:00 PM ET Firm Individuals John Nesbett -...
From Trump to commerce, FX to Brexit, ING’s worldwide economists have it coated. Go to ING.com/THINK to stay a step...
Q1: 2025-05-08 Earnings AbstractEPS of -$0.16 misses by $0.08 | Income of $2.15B (-4.38% Y/Y) misses by $4.50MThis text was written...
MARA Holdings, Inc. (NASDAQ:MARA) Q1 2025 Earnings Conference Title Might 8, 2025 5:00 PM ET Agency Members Robert Samuels –...
Nu Pores and skin Enterprises, Inc. (NYSE:NUS) Q1 2025 Earnings Convention Name Could 8, 2025 5:00 PM ET Firm Members...
Sempra (NYSE:SRE) Q1 2025 Earnings Conference Identify Might 8, 2025 12:00 PM ET Agency Members Glen Donovan – SVP, Finance...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
